Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jul 15;89(4):722-8.
doi: 10.1016/j.ijrobp.2014.03.048. Epub 2014 May 24.

Targeting the Renin-angiotensin system combined with an antioxidant is highly effective in mitigating radiation-induced lung damage

Affiliations

Targeting the Renin-angiotensin system combined with an antioxidant is highly effective in mitigating radiation-induced lung damage

Javed Mahmood et al. Int J Radiat Oncol Biol Phys. .

Abstract

Purpose: To investigate the outcome of suppression of the renin angiotensin system using captopril combined with an antioxidant (Eukarion [EUK]-207) for mitigation of radiation-induced lung damage in rats.

Methods and materials: The thoracic cavity of female Sprague-Dawley rats was irradiated with a single dose of 11 Gy. Treatment with captopril at a dose of 40 mg/kg/d in drinking water and EUK-207 given by subcutaneous injection (8 mg/kg daily) was started 1 week after irradiation (PI) and continuing until 14 weeks PI. Breathing rate was monitored until the rats were killed at 32 weeks PI, when lung fibrosis was assessed by lung hydroxyproline content. Lung levels of the cytokine transforming growth factor-β1 and macrophage activation were analyzed by immunohistochemistry. Oxidative DNA damage was assessed by 8-hydroxy-2-deoxyguanosine levels, and lipid peroxidation was measured by a T-BARS assay.

Results: The increase in breathing rate in the irradiated rats was significantly reduced by the drug treatments. The drug treatment also significantly decreased the hydroxyproline content, 8-hydroxy-2-deoxyguanosine and malondialdehyde levels, and levels of activated macrophages and the cytokine transforming growth factor-β1 at 32 weeks. Almost complete mitigation of these radiation effects was observed by combining captopril and EUK-207.

Conclusion: Captopril and EUK-207 can provide mitigation of radiation-induced lung damage out to at least 32 weeks PI after treatment given 1-14 weeks PI. Overall the combination of captopril and EUK-207 was more effective than the individual drugs used alone.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Breathing rate (mean breaths per minute) as a function of time after irradiation. Control = No irradiation; WTR = whole thorax irradiation (11Gy); WTR+Euk = whole thorax irradiation + Euk-207; WTR+Capt = whole thorax irradiation + Captopril; WTR+Euk+Capt = whole thorax irradiation + Euk-207 + Captopril; Euk+Capt = Euk-207 + Captopril. The drug treatments were started 1 week post-irradiation (PI) and terminated at 14 weeks PI. The rats were euthanized at 32 weeks PI. Each point represents the mean (±SEM) for all rats available for analysis at the different times. All groups contained 8 rats at the start of the experiment. At 8 weeks this was reduced to 6 rats for the WTR group and to 7 rats for the WTR + Euk-207 group and the WTR + Capt group due to morbidity requiring euthanasia. These numbers remained constant out to sacrifice at 32 weeks.
Figure 2
Figure 2
Body weight (mean in grams) as a function of time after irradiation. Labeling of the treatment groups (and number of rats per group) as indicated in the legend to Figure 1. Each point represents the mean (±SEM) for all rats available for analysis at the different times.
Figure 3
Figure 3
A) Hydroxyproline (µg of hydroxyproline/100mg of wet lung tissue) content of the lung tissue at 32 weeks after irradiation; B) Aperio analysis of TGF-beta staining (percent positivity) at 32 weeks after irradiation. C) Definiens analysis of TGF-beta staining (percent of cells stained). Each bar represents the mean (±SEM) for all rats available for analysis. Labeling of the treatment groups (and number of rats per group) as indicated in the legend to Figure 1. The asterisks indicate groups that are significantly different from the WTR group in each panel.
Figure 4
Figure 4
A) Analysis of 8-OHdG staining (percent positivity assessed using Tissue Scope) at 32 weeks after irradiation; B) Analysis of MDA levels (mM) in the lung tissue at 32 weeks after irradiation. Each bar represents the mean (±SEM) for all rats available for analysis. Labeling of the treatment groups (and number of rats per group) as indicated in the legend to Figure 1. The asterisks indicate groups that are significantly different from the WTR group in each panel.
Figure 5
Figure 5
Analysis of macrophage activation (ED-1 staining) at 32 weeks after irradiation as percent positivity (assessed using Tissue Scope). Each bar represents the mean (±SEM). Labeling of the treatment groups (and number of rats per group) as indicated in the legend to Figure 1. The asterisks indicate groups that are significantly different from the WTR group.

Similar articles

Cited by

References

    1. Drouet M, Herodin F. Radiation victim management and the haematologist in the future: time to revisit therapeutic guidelines? Int J Radiat Biol. 2010;86(8):636–648. - PubMed
    1. Fleckenstein K, et al. Using biological markers to predict risk of radiation injury. Semin Radiat Oncol. 2007;17(2):89–98. - PubMed
    1. Ghafoori P, et al. Radiation-induced lung injury. Assessment, management, and prevention. Oncology (Williston Park) 2008;22(1):37–47. discussion 52-3. - PubMed
    1. Molthen RC, et al. Mitigation of radiation induced pulmonary vascular injury by delayed treatment with captopril. Respirology. 2012;17(8):1261–1268. - PMC - PubMed
    1. Hensley ML, et al. American Society of Clinical Oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants. J Clin Oncol. 1999;17(10):3333–3355. - PubMed

Publication types

MeSH terms